TCMD (Tactile Systems Technology) Risk Assessment


TCMD Tactile Systems Technology Inc TCMD
74 GF Score
Price $30.64
GF Value $18.74
Valuation Significantly Overvalued
! 3 Warning Signs
View Full Analysis

What is Tactile Systems Technology Risk Assessment?

Risk Assessment represents the investment risk of a stock derived from our exclusive method. It suggests how risky the investment opportunity is based on the valuation and the fundamental performance of the stock. It is derived from following key aspects:

1. GuruFocus internally developed valuations of the stock, such as GF valuation.
2. Quality Rank, a business quality indicator developed by GuruFocus.
3. Fundamental performance: Piotroski F-Score, Altman Z-Score, Beneish M-Score, etc.
4. Growth opportunities: 5-year revenue growth rate, 5-Year EPS without NRI Growth Rate, etc.

Value investors are always willing to find undervalued stocks. However, not all the undervalued stocks are good deals, we should also be careful of how risky the investment opportunity is. We believe that if the company's financial strength and profitability are strong, and the stock price is within a reasonable range of the GF valuation, or stock has a high return with its price being undervalued, then it might be a good investment opportunity with low risk.

Based on those aspects listed above, GuruFocus believes the risk assessment of Tactile Systems Technology is: Low Risk: Strong fundamentals, worth long-term holding.

Tactile Systems Technology  (NAS:TCMD) Risk Assessment Explanation

Based on the four aspects listed above, GuruFocus provides the following 7 evaluations:

All-in-One Screener Examples (1)
Low Risk: Strong fundamentals, worth long-term holding
Moderate Risk: Sensitive, better choose undervalued stock
High Risk: High uncertainty with risk-return tradeoff
High Risk: Good fundamentals, beware of shrinking business
High Risk: Sensitive to economic or industry trends
High Risk: High uncertainty
No Data: Cannot be evaluated

(1) These are some simple examples. You can access our Risk Assessment filter under All-in-One Screener’s Fundamental tab and set your own criteria.

Tactile Systems Technology Risk Assessment Related Terms

TCMD vs SSII, BVS, BBNX: Risk Assessment Comparison

For the Medical Devices subindustry, Tactile Systems Technology's Risk Assessment, along with its competitors' market caps and Risk Assessment data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Tactile Systems Technology Risk Assessment vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Tactile Systems Technology's Risk Assessment distribution charts can be found below:

* The bar in red indicates where Tactile Systems Technology's Risk Assessment falls into.


TCMD
74GF Score
Tactile Systems Technology Inc TCMD
Risk Assessment is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Tactile Systems Technology (TCMD) Overvalued in 2026?

Based on GuruFocus' analysis, Tactile Systems Technology stock appears to be overvalued. The current stock price of $30.64 is trading 63.5% above its estimated GF Value™ of $18.74. GuruFocus considers Tactile Systems Technology to be Significantly Overvalued.

Key valuation signals for TCMD:

  • Risk Assessment:
  • GF Value™: $18.74 vs. price of $30.64 (63.5% above fair value)
  • GF Score™: 74/100 with 3 warning signs

No single metric tells the full story. See the TCMD stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Tactile Systems Technology Business Description

Other Exchanges 3L3:Germany
Address 3701 Wayzata Boulevard, Suite 300, Minneapolis, MN, USA, 55416
Tactile Systems Technology Inc is a medical technology company. The company is engaged in developing and providing medical devices for the treatment of chronic diseases. The firm's proprietary platform flexitouch system, provides a home-based solution for lymphedema patients. The entire system is another home solution for patients with chronic swelling and actitouch system for chronic venous insufficiency patients that may be worn throughout the day.
74GF Score

Get the complete analysis for TCMD

Risk Assessment is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$30.64
Price
$18.74
GF Value